Blockade of Type I Interferon (IFN) Production by Retroviral Replicating Vectors and Reduced Tumor Cell Responses to IFN Likely Contribute To Tumor Selectivity

Por Lin, Amy H., Burrascano, Cindy, Pettersson, Par L., Ibañez, Carlos E., Gruber, Harry E., Jolly, Douglas J.
Publicado em 2014

Production of unique immunotoxin cancer therapeutics in algal chloroplasts

Por Tran, Miller, Van, Christina, Barrera, Daniel J., Pettersson, Pär L., Peinado, Carlos D., Bui, Jack, Mayfield, Stephen P.
Publicado em 2013

Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids

Por Burnett, Ryan, Ibañez, Carlos E., Pettersson, Pär L., Chen, Ching-I, Parab, Shraddha, Huang, Tiffany, Robbins, Joan, Bankiewicz, Krystof, Aghi, Manish, Logg, Christopher, Kasahara, Noriyuki, Pertschuk, Dan, Gruber, Harry E., Jolly, Douglas J.
Publicado no Mol Ther Methods Clin Dev (2014)

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

Por Ostertag, Derek, Amundson, Karin K., Lopez Espinoza, Fernando, Martin, Bryan, Buckley, Taylor, da Silva, Ana Paula Galvão, Lin, Amy H., Valenta, David T., Perez, Omar D., Ibañez, Carlos E., Chen, Ching-I, Pettersson, Pär L., Burnett, Ryan, Daublebsky, Veronika, Hlavaty, Juraj, Gunzburg, Walter, Kasahara, Noriyuki, Gruber, Harry E., Jolly, Douglas J., Robbins, Joan M.
Publicado em 2012